Adenosarcoma of the Uterus

Tsunehisa Kaku, S G Silverberg, Francis J. Major, Bernard F. Fetter, Mark F. Brady

International Journal of Gynecological Pathology · 1992 · 180 citations · 0 references

TL;DR

The authors recommend staging laparotomy with peritoneal cytology for clinical stage I–II uterine adenosarcoma and discuss its differential diagnosis. They reviewed clinical and pathological data from 31 uterine adenosarcoma patients who underwent hysterectomy and staging laparotomy. Among these patients, 30 % recurred and 20 % died within a mean 38.3‑month follow‑up; sarcomatous overgrowth (17/31) and extrauterine spread were linked to higher recurrence, while rhabdomyosarcomatous differentiation and lymphovascular invasion suggested poorer prognosis.

Abstract

Summary We report on the clinical and pathologic findings in 31 cases of adenosarcoma of the uterus subjected to hysterectomy and staging laparotomy. Nine of 30 patients (30%) have had recurrent tumor and six of 30 (20%) have already died of tumor in a relatively short follow-up period (mean, 38.3 months). Seventeen of 31 cases were diagnosed as adenosarcoma with sarcomatous overgrowth (SO). Ten of these 17 with SO contained focal or extensive rhabdomyosarcoma. In six cases, extrauterine spread was identified as follows (two patients had two sites each): vaginal involvement (two cases), pelvic lymph node metastases (two), positive peritoneal cytologic findings (two), parametrial invasion (one), and ovarian metastasis (one). Extrauterine spread (stage III) (p < 0.001) and myometrial invasion (p = 0.04) were associated with higher rates of recurrence. The presence of lymphatic and/or vascular invasion, SO, and rhabdomyosarcomatous differentiation also indicated poor prognosis but did not attain statistical significance. Based on this experience, staging laparotomy including peritoneal cytology is suggested in cases of clinical stages I and II adenosarcoma. The differential diagnosis of these tumors is also discussed.